Related Experiment Video
Updated: Sep 4, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Correlation of SARS-CoV-2 infection severity with ABO blood groups and RhD antigen: a case-control study
Nazaneen Akbar Omer1, Sarwer Jamal Al-Bajalan2, Heshu Sulaiman Rahman3,4
1Department of Medical Biochemistry, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq.
Insights
This study found no link between blood types (ABO and RhD) and the severity of coronavirus disease 2019 (COVID-19) or hospitalization risk in Iraqi-Kurdish patients. Blood group does not appear to influence COVID-19 outcomes.
Area of Science:
- Immunology
- Infectious Diseases
- Genetics
Background:
- Previous research explored links between ABO blood groups and COVID-19 severity.
- The RhD antigen's role in COVID-19 outcomes also remains an area of interest.
Purpose of the Study:
- To investigate the association between ABO blood groups and RhD antigen status with symptomatic COVID-19.
- To determine if specific blood types increase the risk of hospitalization due to COVID-19.
Main Methods:
- An observational case-control study involving 530 Iraqi-Kurdish COVID-19 patients.
- Patients were categorized into severe (hospitalized) and mild/moderate (home-treated) groups.
- Comparison of ABO and RhD antigen distributions with 1698 pre-pandemic control records.
Main Results:
- No significant differences in ABO and RhD antigen distributions were observed between COVID-19 cases and controls.
- No specific ABO blood group was identified as a risk factor for hospitalization, indicating no association with infection severity.
Conclusions:
- No significant association was found between symptomatic COVID-19 and ABO blood groups or RhD antigen types.
- ABO blood groups did not demonstrate an impact on hospitalization rates for COVID-19 patients.
Objective:
The role of ABO types and RhD antigen in coronavirus disease 2019 (COVID-19) severity has been investigated in several recent studies. Thus, the objective of this study was to identify the relationship of ABO and RhD types with symptomatic COVID-19 disease and determine the groups associated with an increased risk of hospitalization.
Methods:
This observational case-control study was performed in 530 Iraqi-Kurdish patients with COVID-19. Among them, 184 were severe cases that required hospitalization, while 346 were mild to moderate cases that were treated at home. ABO and RhD antigen groups were compared between cases and 1698 control records from 1 year before the pandemic. The diagnosis of COVID-19 was based on real-time polymerase chain reaction tests and high-resolution chest computed tomography scans with the typical clinical presentation.
Results:
There were no significant differences in ABO and RhD antigen distributions between the COVID-19 cases and non-COVID controls. No ABO group was associated with the risk of hospitalization as a marker of the severity of infection.
Conclusions:
There was no significant association between symptomatic COVID-19 disease and any ABO group or RhD antigen type. No impact of ABO groups on hospitalization was documented.
Related Concept Videos
Rh Blood Group
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

